Artificial Antigen Presenting Cells for Detection and Desensitization of Autoreactive T cells Associated with Type 1 Diabetes

Autoimmune diseases and in particular type 1 diabetes rely heavily on treatments that target the symptoms rather than prevent the underlying disease. One of the barriers to better therapeutic strategies is the inability to detect and efficiently target rare autoreactive T-cell populations that are m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nano letters 2022-06, Vol.22 (11), p.4376-4382
Hauptverfasser: Artzy-Schnirman, Arbel, Abu-Shah, Enas, Chandrawati, Rona, Altman, Efrat, Yusuf, Norkhairin, Wang, Shih-Ting, Ramos, Jose, Hansel, Catherine S., Haus-Cohen, Maya, Dahan, Rony, Arif, Sefina, Dustin, Michael L., Peakman, Mark, Reiter, Yoram, Stevens, Molly M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4382
container_issue 11
container_start_page 4376
container_title Nano letters
container_volume 22
creator Artzy-Schnirman, Arbel
Abu-Shah, Enas
Chandrawati, Rona
Altman, Efrat
Yusuf, Norkhairin
Wang, Shih-Ting
Ramos, Jose
Hansel, Catherine S.
Haus-Cohen, Maya
Dahan, Rony
Arif, Sefina
Dustin, Michael L.
Peakman, Mark
Reiter, Yoram
Stevens, Molly M.
description Autoimmune diseases and in particular type 1 diabetes rely heavily on treatments that target the symptoms rather than prevent the underlying disease. One of the barriers to better therapeutic strategies is the inability to detect and efficiently target rare autoreactive T-cell populations that are major drivers of these conditions. Here, we develop a unique artificial antigen-presenting cell (aAPC) system from biocompatible polymer particles that allows specific encapsulation of bioactive ingredients. Using our aAPC, we demonstrate that we are able to detect rare autoreactive CD4 populations in human patients, and using mouse models, we demonstrate that our particles are able to induce desensitization in the autoreactive population. This system provides a promising tool that can be used in the prevention of autoimmunity before disease onset.
doi_str_mv 10.1021/acs.nanolett.2c00819
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9185737</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2670062763</sourcerecordid><originalsourceid>FETCH-LOGICAL-a449t-88b6e11bb929e6aa0b5c389a5c47344c2417be6319a4612c8e2044c6396e4953</originalsourceid><addsrcrecordid>eNp9kUtvEzEUhS1ERV_8A4S8ZJPg94w3SKMUKFKldpG95XHupK4mdrA9rYrEf8dp0gg2rHx9_Z1jXx-EPlAyp4TRz9blebAhjlDKnDlCWqrfoDMqOZkprdnbY92KU3Se8wMhRHNJ3qFTLhVVksoz9LtLxQ_eeTviLhS_hoDvEmSodVjjBYxjxkNM-AoKuOJjwDas6q4S2Rf_y7704oC7qcQEtjKPgJfYvSi7nGP1LrDCT77c4-XzFjDFV9721S9fopPBjhneH9YLtPz2dbm4nt3cfv-x6G5mVghdZm3bK6C07zXToKwlvXS81VY60XAhHBO06UFxqq1QlLkWGKltxbUCoSW_QF_2ttup38DK1eGSHc02-Y1NzyZab_49Cf7erOOj0bSVDW-qwaeDQYo_J8jFbHzeTWgDxCkbphpCFGsUr6jYoy7FnBMMx2soMbvgTA3OvAZnDsFV2ce_n3gUvSZVAbIHdvKHOKVQP-z_nn8A8QGqlg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2670062763</pqid></control><display><type>article</type><title>Artificial Antigen Presenting Cells for Detection and Desensitization of Autoreactive T cells Associated with Type 1 Diabetes</title><source>American Chemical Society Journals</source><creator>Artzy-Schnirman, Arbel ; Abu-Shah, Enas ; Chandrawati, Rona ; Altman, Efrat ; Yusuf, Norkhairin ; Wang, Shih-Ting ; Ramos, Jose ; Hansel, Catherine S. ; Haus-Cohen, Maya ; Dahan, Rony ; Arif, Sefina ; Dustin, Michael L. ; Peakman, Mark ; Reiter, Yoram ; Stevens, Molly M.</creator><creatorcontrib>Artzy-Schnirman, Arbel ; Abu-Shah, Enas ; Chandrawati, Rona ; Altman, Efrat ; Yusuf, Norkhairin ; Wang, Shih-Ting ; Ramos, Jose ; Hansel, Catherine S. ; Haus-Cohen, Maya ; Dahan, Rony ; Arif, Sefina ; Dustin, Michael L. ; Peakman, Mark ; Reiter, Yoram ; Stevens, Molly M.</creatorcontrib><description>Autoimmune diseases and in particular type 1 diabetes rely heavily on treatments that target the symptoms rather than prevent the underlying disease. One of the barriers to better therapeutic strategies is the inability to detect and efficiently target rare autoreactive T-cell populations that are major drivers of these conditions. Here, we develop a unique artificial antigen-presenting cell (aAPC) system from biocompatible polymer particles that allows specific encapsulation of bioactive ingredients. Using our aAPC, we demonstrate that we are able to detect rare autoreactive CD4 populations in human patients, and using mouse models, we demonstrate that our particles are able to induce desensitization in the autoreactive population. This system provides a promising tool that can be used in the prevention of autoimmunity before disease onset.</description><identifier>ISSN: 1530-6984</identifier><identifier>EISSN: 1530-6992</identifier><identifier>DOI: 10.1021/acs.nanolett.2c00819</identifier><identifier>PMID: 35616515</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Letter</subject><ispartof>Nano letters, 2022-06, Vol.22 (11), p.4376-4382</ispartof><rights>2022 The Authors. Published by American Chemical Society</rights><rights>2022 The Authors. Published by American Chemical Society 2022 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a449t-88b6e11bb929e6aa0b5c389a5c47344c2417be6319a4612c8e2044c6396e4953</citedby><cites>FETCH-LOGICAL-a449t-88b6e11bb929e6aa0b5c389a5c47344c2417be6319a4612c8e2044c6396e4953</cites><orcidid>0000-0002-2173-7410 ; 0000-0003-4983-6389 ; 0000-0002-2525-1856 ; 0000-0002-7335-266X ; 0000-0002-9780-8844 ; 0000-0002-7634-8332</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.nanolett.2c00819$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.nanolett.2c00819$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,314,780,784,885,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35616515$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Artzy-Schnirman, Arbel</creatorcontrib><creatorcontrib>Abu-Shah, Enas</creatorcontrib><creatorcontrib>Chandrawati, Rona</creatorcontrib><creatorcontrib>Altman, Efrat</creatorcontrib><creatorcontrib>Yusuf, Norkhairin</creatorcontrib><creatorcontrib>Wang, Shih-Ting</creatorcontrib><creatorcontrib>Ramos, Jose</creatorcontrib><creatorcontrib>Hansel, Catherine S.</creatorcontrib><creatorcontrib>Haus-Cohen, Maya</creatorcontrib><creatorcontrib>Dahan, Rony</creatorcontrib><creatorcontrib>Arif, Sefina</creatorcontrib><creatorcontrib>Dustin, Michael L.</creatorcontrib><creatorcontrib>Peakman, Mark</creatorcontrib><creatorcontrib>Reiter, Yoram</creatorcontrib><creatorcontrib>Stevens, Molly M.</creatorcontrib><title>Artificial Antigen Presenting Cells for Detection and Desensitization of Autoreactive T cells Associated with Type 1 Diabetes</title><title>Nano letters</title><addtitle>Nano Lett</addtitle><description>Autoimmune diseases and in particular type 1 diabetes rely heavily on treatments that target the symptoms rather than prevent the underlying disease. One of the barriers to better therapeutic strategies is the inability to detect and efficiently target rare autoreactive T-cell populations that are major drivers of these conditions. Here, we develop a unique artificial antigen-presenting cell (aAPC) system from biocompatible polymer particles that allows specific encapsulation of bioactive ingredients. Using our aAPC, we demonstrate that we are able to detect rare autoreactive CD4 populations in human patients, and using mouse models, we demonstrate that our particles are able to induce desensitization in the autoreactive population. This system provides a promising tool that can be used in the prevention of autoimmunity before disease onset.</description><subject>Letter</subject><issn>1530-6984</issn><issn>1530-6992</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kUtvEzEUhS1ERV_8A4S8ZJPg94w3SKMUKFKldpG95XHupK4mdrA9rYrEf8dp0gg2rHx9_Z1jXx-EPlAyp4TRz9blebAhjlDKnDlCWqrfoDMqOZkprdnbY92KU3Se8wMhRHNJ3qFTLhVVksoz9LtLxQ_eeTviLhS_hoDvEmSodVjjBYxjxkNM-AoKuOJjwDas6q4S2Rf_y7704oC7qcQEtjKPgJfYvSi7nGP1LrDCT77c4-XzFjDFV9721S9fopPBjhneH9YLtPz2dbm4nt3cfv-x6G5mVghdZm3bK6C07zXToKwlvXS81VY60XAhHBO06UFxqq1QlLkWGKltxbUCoSW_QF_2ttup38DK1eGSHc02-Y1NzyZab_49Cf7erOOj0bSVDW-qwaeDQYo_J8jFbHzeTWgDxCkbphpCFGsUr6jYoy7FnBMMx2soMbvgTA3OvAZnDsFV2ce_n3gUvSZVAbIHdvKHOKVQP-z_nn8A8QGqlg</recordid><startdate>20220608</startdate><enddate>20220608</enddate><creator>Artzy-Schnirman, Arbel</creator><creator>Abu-Shah, Enas</creator><creator>Chandrawati, Rona</creator><creator>Altman, Efrat</creator><creator>Yusuf, Norkhairin</creator><creator>Wang, Shih-Ting</creator><creator>Ramos, Jose</creator><creator>Hansel, Catherine S.</creator><creator>Haus-Cohen, Maya</creator><creator>Dahan, Rony</creator><creator>Arif, Sefina</creator><creator>Dustin, Michael L.</creator><creator>Peakman, Mark</creator><creator>Reiter, Yoram</creator><creator>Stevens, Molly M.</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2173-7410</orcidid><orcidid>https://orcid.org/0000-0003-4983-6389</orcidid><orcidid>https://orcid.org/0000-0002-2525-1856</orcidid><orcidid>https://orcid.org/0000-0002-7335-266X</orcidid><orcidid>https://orcid.org/0000-0002-9780-8844</orcidid><orcidid>https://orcid.org/0000-0002-7634-8332</orcidid></search><sort><creationdate>20220608</creationdate><title>Artificial Antigen Presenting Cells for Detection and Desensitization of Autoreactive T cells Associated with Type 1 Diabetes</title><author>Artzy-Schnirman, Arbel ; Abu-Shah, Enas ; Chandrawati, Rona ; Altman, Efrat ; Yusuf, Norkhairin ; Wang, Shih-Ting ; Ramos, Jose ; Hansel, Catherine S. ; Haus-Cohen, Maya ; Dahan, Rony ; Arif, Sefina ; Dustin, Michael L. ; Peakman, Mark ; Reiter, Yoram ; Stevens, Molly M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a449t-88b6e11bb929e6aa0b5c389a5c47344c2417be6319a4612c8e2044c6396e4953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Letter</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Artzy-Schnirman, Arbel</creatorcontrib><creatorcontrib>Abu-Shah, Enas</creatorcontrib><creatorcontrib>Chandrawati, Rona</creatorcontrib><creatorcontrib>Altman, Efrat</creatorcontrib><creatorcontrib>Yusuf, Norkhairin</creatorcontrib><creatorcontrib>Wang, Shih-Ting</creatorcontrib><creatorcontrib>Ramos, Jose</creatorcontrib><creatorcontrib>Hansel, Catherine S.</creatorcontrib><creatorcontrib>Haus-Cohen, Maya</creatorcontrib><creatorcontrib>Dahan, Rony</creatorcontrib><creatorcontrib>Arif, Sefina</creatorcontrib><creatorcontrib>Dustin, Michael L.</creatorcontrib><creatorcontrib>Peakman, Mark</creatorcontrib><creatorcontrib>Reiter, Yoram</creatorcontrib><creatorcontrib>Stevens, Molly M.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nano letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Artzy-Schnirman, Arbel</au><au>Abu-Shah, Enas</au><au>Chandrawati, Rona</au><au>Altman, Efrat</au><au>Yusuf, Norkhairin</au><au>Wang, Shih-Ting</au><au>Ramos, Jose</au><au>Hansel, Catherine S.</au><au>Haus-Cohen, Maya</au><au>Dahan, Rony</au><au>Arif, Sefina</au><au>Dustin, Michael L.</au><au>Peakman, Mark</au><au>Reiter, Yoram</au><au>Stevens, Molly M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Artificial Antigen Presenting Cells for Detection and Desensitization of Autoreactive T cells Associated with Type 1 Diabetes</atitle><jtitle>Nano letters</jtitle><addtitle>Nano Lett</addtitle><date>2022-06-08</date><risdate>2022</risdate><volume>22</volume><issue>11</issue><spage>4376</spage><epage>4382</epage><pages>4376-4382</pages><issn>1530-6984</issn><eissn>1530-6992</eissn><abstract>Autoimmune diseases and in particular type 1 diabetes rely heavily on treatments that target the symptoms rather than prevent the underlying disease. One of the barriers to better therapeutic strategies is the inability to detect and efficiently target rare autoreactive T-cell populations that are major drivers of these conditions. Here, we develop a unique artificial antigen-presenting cell (aAPC) system from biocompatible polymer particles that allows specific encapsulation of bioactive ingredients. Using our aAPC, we demonstrate that we are able to detect rare autoreactive CD4 populations in human patients, and using mouse models, we demonstrate that our particles are able to induce desensitization in the autoreactive population. This system provides a promising tool that can be used in the prevention of autoimmunity before disease onset.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>35616515</pmid><doi>10.1021/acs.nanolett.2c00819</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-2173-7410</orcidid><orcidid>https://orcid.org/0000-0003-4983-6389</orcidid><orcidid>https://orcid.org/0000-0002-2525-1856</orcidid><orcidid>https://orcid.org/0000-0002-7335-266X</orcidid><orcidid>https://orcid.org/0000-0002-9780-8844</orcidid><orcidid>https://orcid.org/0000-0002-7634-8332</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1530-6984
ispartof Nano letters, 2022-06, Vol.22 (11), p.4376-4382
issn 1530-6984
1530-6992
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9185737
source American Chemical Society Journals
subjects Letter
title Artificial Antigen Presenting Cells for Detection and Desensitization of Autoreactive T cells Associated with Type 1 Diabetes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A25%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Artificial%20Antigen%20Presenting%20Cells%20for%20Detection%20and%20Desensitization%20of%20Autoreactive%20T%20cells%20Associated%20with%20Type%201%20Diabetes&rft.jtitle=Nano%20letters&rft.au=Artzy-Schnirman,%20Arbel&rft.date=2022-06-08&rft.volume=22&rft.issue=11&rft.spage=4376&rft.epage=4382&rft.pages=4376-4382&rft.issn=1530-6984&rft.eissn=1530-6992&rft_id=info:doi/10.1021/acs.nanolett.2c00819&rft_dat=%3Cproquest_pubme%3E2670062763%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2670062763&rft_id=info:pmid/35616515&rfr_iscdi=true